Advanced search
Publication Cover
Clinical Toxicology Volume 56, 2018 - Issue 4
Submit an article Journal homepage
233
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Baclofen and the “first do not harm” motto: a new French paradox?

Alain BraillonDepartment of Medicine, University Hospital, Amiens, France; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-5735-9530
ORCID Icon &
Florian NaudetMeta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA
Pages 307-308 | Received 20 Apr 2017, Accepted 07 Aug 2017, Published online: 21 Aug 2017

References

  • Pelissier F, de Haro L, Cardona F, et al. Self-poisoning with baclofen in alcohol-dependent patients: national reports to French PoisonControl Centers, 2008–2013. Clin Toxicol. 2017;55:275–284.
  • Good CB, Gellad WF. Off-label drug use and adverse drug events: turning up the heat on off-label prescribing. JAMA Intern Med. 2016;176:63–64.
  • Eguale T, Buckeridge DL, Verma A, et al. Association of off-label drug use and adverse drug events in an adult population. JAMA Intern Med. 2016;176:55–63.
  • Degrassat-Théas A, Bocquet F, Sinègre M, et al. The “Temporary Recommendations for Use”: a dual-purpose regulatory framework for off-label drug use in France. Health Policy. 2015;119:1399–1405.
  • Olivier PY, Joyeux-Faure M, Gentina T, et al. Severe central sleep apnea associated with chronic baclofen therapy: a case series. Chest. 2016;149:e127–e131.
  • Beraha EM, Salemink E, Goudriaan AE, et al. Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: a multicentre, randomised, double-blind controlled trial. Eur Neuropsychopharmacol. 2016;26:1950–1959.
  • Reynaud M, Aubin HJ, Trinquet F, et al. A randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients – the ALPADIR study. Alcohol Alcohol. 2017;52:439–446.
  • Müller CA, Geisel O, Pelz P, et al. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial. Eur Neuropsychopharmacol. 2015;25:1167–1177.
  • Edelman EJ, Fiellin DA. In the clinic. Alcohol use. Ann Intern Med. 2016;164:ITC1–IT16.
  • Baumann S, Toft U, Aadahl M, et al. The long-term effect of a population-based life-style intervention on smoking and alcohol consumption. The Inter99 Study-a randomized controlled trial. Addiction. 2015;110:1853–1860.
  • Braillon A, Naudet F. Baclofen and alcohol use disorders: from miracle to mirage. Eur Neuropsychopharmacol. 2017;27:691–692.
  • Braillon A. Baclofen and protecting the patients during research. Alcohol Alcohol. 2012;47:631.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.